ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,982Medicare Part D Prescriptions Filled, Including Refills

Rank: 66 out of 1206

$627K Total Retail Price of All Prescriptions

Rank: 74 out of 1206

603 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 603 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 603 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 12,079 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 647 589 1 2
FUROSEMIDE 604 528 2 5
LISINOPRIL 549 490 3 4
SIMVASTATIN 437 410 4 1
OMEPRAZOLE 429 370 5 3
METOPROLOL TARTRATE 351 315 6 9
AMLODIPINE BESYLATE 347 312 7 6
HYDROCHLOROTHIAZIDE 312 298 8 11
POTASSIUM CHLORIDE 308 270 9 12
WARFARIN SODIUM 304 283 10 8
METOPROLOL SUCCINATE 274 256 11 15
METFORMIN HCL 245 178 12 10
LOSARTAN POTASSIUM 240 223 13 20
ATORVASTATIN CALCIUM 218 188 14 13
TRIAMTERENE-HCTZ 213 203 15 33
FLUOXETINE HCL 203 165 16 52
HYDROCODONE-ACETAMINOPHEN 179 122 S3 17 7
ALENDRONATE SODIUM 154 154 18 19
ATENOLOL 153 144 19 14
CRESTOR 149 146 20 30
TRAMADOL HCL 145 129 21 17
DONEPEZIL HCL 141 141 22 29
GABAPENTIN 141 117 22 18
TAMSULOSIN HCL 137 125 24 26
ALLOPURINOL 136 91 25 24
AZITHROMYCIN 128 112 26 46
LANTUS 105 60 27 38
ZOLPIDEM TARTRATE 103 78 28 25
NAMENDA 101 101 29 36
GLIMEPIRIDE 101 72 29 34
CLOPIDOGREL 99 81 31 48
PRAVASTATIN SODIUM 98 98 32 21
PREDNISONE 95 84 33 28
MELOXICAM 91 78 34 35
GLIPIZIDE 87 81 35 64
CIPROFLOXACIN HCL 87 81 35 61
LANTUS SOLOSTAR 85 84 37 85
ACTOS 84 65 38 98
QUETIAPINE FUMARATE 81 81 39 79
CITALOPRAM HBR 80 64 40 16
ISOSORBIDE MONONITRATE ER 80 68 40 40
PLAVIX 79 70 42 72
DILTIAZEM 24HR CD 77 63 43 67
SERTRALINE HCL 77 49 43 22
KLOR-CON M20 74 62 45 126
RANITIDINE HCL 73 59 46 23
CARVEDILOL 72 72 47 32
NABUMETONE 71 47 48 91
DIGOXIN 69 69 49 43
DIVALPROEX SODIUM ER 67 43 50 163
LANSOPRAZOLE 66 60 51 128
CEPHALEXIN 66 57 51 62
FENTANYL 64 63 S2 53 51
NEXIUM 61 60 54 47
BYSTOLIC 61 61 54 109
PROPRANOLOL HCL 60 36 56 92
VENLAFAXINE HCL ER 59 42 57 89
LEVETIRACETAM 59 20 57 135
ESCITALOPRAM OXALATE 59 59 57 86
PROAIR HFA 58 45 60 49
POLYETHYLENE GLYCOL 3350 55 42 61 31
TRAZODONE HCL 54 44 62 37
AMOXICILLIN 54 49 62 122
BACLOFEN 53 16 64 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.